Annual Gross Profit
$8.61 B
+$756.60 M+9.64%
31 December 2023
Summary:
Vertex Pharmaceuticals Incorporated annual gross profit is currently $8.61 billion, with the most recent change of +$756.60 million (+9.64%) on 31 December 2023. During the last 3 years, it has risen by +$3.14 billion (+57.37%). VRTX annual gross profit is now at all-time high.VRTX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$2.38 B
+$105.60 M+4.64%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated quarterly gross profit is currently $2.38 billion, with the most recent change of +$105.60 million (+4.64%) on 30 September 2024. Over the past year, it has increased by +$214.50 million (+9.91%). VRTX quarterly gross profit is now at all-time high.VRTX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$9.15 B
+$214.50 M+2.40%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated TTM gross profit is currently $9.15 billion, with the most recent change of +$214.50 million (+2.40%) on 30 September 2024. Over the past year, it has increased by +$674.00 million (+7.95%). VRTX TTM gross profit is now at all-time high.VRTX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.6% | +9.9% | +8.0% |
| 3 y3 years | +57.4% | +36.1% | +46.0% |
| 5 y5 years | +226.3% | +190.9% | +191.9% |
VRTX Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +57.4% | at high | +36.1% | at high | +46.0% |
| 5 y | 5 years | at high | +226.3% | at high | +190.9% | at high | +191.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Vertex Pharmaceuticals Incorporated Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.38 B(+4.6%) | $9.15 B(+2.4%) |
| June 2024 | - | $2.27 B(-3.2%) | $8.94 B(+1.0%) |
| Mar 2024 | - | $2.35 B(+9.2%) | $8.85 B(+2.8%) |
| Dec 2023 | $8.61 B(+9.6%) | $2.15 B(-0.7%) | $8.61 B(+1.5%) |
| Sept 2023 | - | $2.16 B(-0.9%) | $8.48 B(+1.4%) |
| June 2023 | - | $2.18 B(+3.6%) | $8.36 B(+3.1%) |
| Mar 2023 | - | $2.11 B(+4.4%) | $8.11 B(+3.3%) |
| Dec 2022 | $7.85 B(+17.7%) | $2.02 B(-1.2%) | $7.85 B(+2.5%) |
| Sept 2022 | - | $2.04 B(+5.7%) | $7.66 B(+4.0%) |
| June 2022 | - | $1.93 B(+4.5%) | $7.36 B(+5.3%) |
| Mar 2022 | - | $1.85 B(+1.5%) | $6.99 B(+4.8%) |
| Dec 2021 | $6.67 B(+22.0%) | $1.83 B(+4.4%) | $6.67 B(+6.4%) |
| Sept 2021 | - | $1.75 B(+11.6%) | $6.27 B(+6.7%) |
| June 2021 | - | $1.57 B(+2.2%) | $5.87 B(+4.0%) |
| Mar 2021 | - | $1.53 B(+7.5%) | $5.65 B(+3.3%) |
| Dec 2020 | $5.47 B(+51.3%) | $1.42 B(+5.4%) | $5.47 B(+3.7%) |
| Sept 2020 | - | $1.35 B(+0.9%) | $5.27 B(+11.3%) |
| June 2020 | - | $1.34 B(-0.9%) | $4.74 B(+12.7%) |
| Mar 2020 | - | $1.35 B(+10.1%) | $4.20 B(+16.3%) |
| Dec 2019 | $3.62 B(+37.0%) | $1.23 B(+50.2%) | $3.62 B(+15.3%) |
| Sept 2019 | - | $817.91 M(+1.5%) | $3.13 B(+4.8%) |
| June 2019 | - | $805.55 M(+5.5%) | $2.99 B(+5.6%) |
| Mar 2019 | - | $763.34 M(+2.1%) | $2.83 B(+7.4%) |
| Dec 2018 | $2.64 B(+19.2%) | $747.82 M(+11.1%) | $2.64 B(+7.3%) |
| Sept 2018 | - | $673.28 M(+3.9%) | $2.46 B(+7.3%) |
| June 2018 | - | $647.77 M(+13.8%) | $2.29 B(+8.3%) |
| Mar 2018 | - | $569.19 M(+0.3%) | $2.11 B(-4.5%) |
| Dec 2017 | $2.21 B(+48.4%) | $567.58 M(+12.3%) | $2.21 B(+8.3%) |
| Sept 2017 | - | $505.29 M(+6.8%) | $2.04 B(+7.7%) |
| June 2017 | - | $472.93 M(-29.2%) | $1.90 B(+4.8%) |
| Mar 2017 | - | $667.73 M(+67.7%) | $1.81 B(+21.5%) |
| Dec 2016 | $1.49 B(+64.3%) | $398.22 M(+10.7%) | $1.49 B(+3.0%) |
| Sept 2016 | - | $359.71 M(-6.9%) | $1.45 B(+6.0%) |
| June 2016 | - | $386.36 M(+11.2%) | $1.37 B(+21.0%) |
| Mar 2016 | - | $347.43 M(-2.0%) | $1.13 B(+24.4%) |
| Dec 2015 | $907.82 M(+74.8%) | $354.55 M(+27.6%) | $907.82 M(+32.8%) |
| Sept 2015 | - | $277.86 M(+86.2%) | $683.80 M(+19.8%) |
| June 2015 | - | $149.22 M(+18.2%) | $570.75 M(+5.2%) |
| Mar 2015 | - | $126.20 M(-3.3%) | $542.65 M(+4.5%) |
| Dec 2014 | $519.43 M(-52.0%) | $130.53 M(-20.8%) | $519.43 M(-27.6%) |
| Sept 2014 | - | $164.80 M(+36.1%) | $717.79 M(-4.0%) |
| June 2014 | - | $121.12 M(+17.6%) | $747.35 M(-16.9%) |
| Mar 2014 | - | $102.97 M(-68.7%) | $899.05 M(-16.9%) |
| Dec 2013 | $1.08 B(-13.3%) | $328.89 M(+69.2%) | $1.08 B(+8.3%) |
| Sept 2013 | - | $194.36 M(-28.8%) | $999.08 M(-9.4%) |
| June 2013 | - | $272.82 M(-4.5%) | $1.10 B(-2.7%) |
| Mar 2013 | - | $285.63 M(+16.0%) | $1.13 B(-9.1%) |
| Dec 2012 | $1.25 B(-6.2%) | $246.28 M(-17.2%) | $1.25 B(-18.7%) |
| Sept 2012 | - | $297.47 M(-2.1%) | $1.53 B(-17.4%) |
| June 2012 | - | $303.88 M(-23.9%) | $1.86 B(+12.0%) |
| Mar 2012 | - | $399.53 M(-25.1%) | $1.66 B(+24.7%) |
| Dec 2011 | $1.33 B(+918.2%) | $533.21 M(-14.1%) | $1.33 B(+54.8%) |
| Sept 2011 | - | $620.79 M(+490.6%) | $859.38 M(+231.6%) |
| June 2011 | - | $105.12 M(+48.1%) | $259.16 M(+41.9%) |
| Mar 2011 | - | $71.00 M(+13.6%) | $182.57 M(+39.8%) |
| Dec 2010 | $130.64 M(+49.0%) | $62.48 M(+203.8%) | $130.64 M(+32.8%) |
| Sept 2010 | - | $20.57 M(-27.9%) | $98.41 M(-0.7%) |
| June 2010 | - | $28.54 M(+49.7%) | $99.08 M(+14.8%) |
| Mar 2010 | - | $19.06 M(-37.0%) | $86.35 M(-1.5%) |
| Dec 2009 | $87.69 M(-45.1%) | $30.24 M(+42.3%) | $87.69 M(+1.9%) |
| Sept 2009 | - | $21.25 M(+34.5%) | $86.04 M(-6.7%) |
| June 2009 | - | $15.80 M(-22.6%) | $92.21 M(-35.1%) |
| Mar 2009 | - | $20.40 M(-28.7%) | $142.12 M(-11.1%) |
| Dec 2008 | $159.82 M(-13.7%) | $28.60 M(+4.3%) | $159.82 M(-10.5%) |
| Sept 2008 | - | $27.41 M(-58.3%) | $178.54 M(-5.3%) |
| June 2008 | - | $65.71 M(+72.5%) | $188.58 M(+19.6%) |
| Mar 2008 | - | $38.10 M(-19.5%) | $157.67 M(-14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $185.11 M(-9.3%) | $47.32 M(+26.3%) | $185.11 M(-19.1%) |
| Sept 2007 | - | $37.45 M(+7.6%) | $228.87 M(-5.3%) |
| June 2007 | - | $34.80 M(-46.9%) | $241.59 M(+3.4%) |
| Mar 2007 | - | $65.54 M(-28.0%) | $233.63 M(+14.4%) |
| Dec 2006 | $204.19 M(+35.4%) | $91.08 M(+81.5%) | $204.19 M(+17.3%) |
| Sept 2006 | - | $50.18 M(+86.9%) | $174.08 M(+10.7%) |
| June 2006 | - | $26.84 M(-25.6%) | $157.32 M(-1.9%) |
| Mar 2006 | - | $36.09 M(-40.8%) | $160.31 M(+6.3%) |
| Dec 2005 | $150.79 M(+55.3%) | $60.97 M(+82.5%) | $150.79 M(+18.1%) |
| Sept 2005 | - | $33.41 M(+12.0%) | $127.64 M(+6.7%) |
| June 2005 | - | $29.83 M(+12.3%) | $119.60 M(+11.8%) |
| Mar 2005 | - | $26.58 M(-29.7%) | $106.98 M(+10.2%) |
| Dec 2004 | $97.07 M(+47.0%) | $37.83 M(+49.1%) | $97.07 M(+21.9%) |
| Sept 2004 | - | $25.36 M(+47.3%) | $79.61 M(+14.9%) |
| June 2004 | - | $17.21 M(+3.3%) | $69.27 M(+1.7%) |
| Mar 2004 | - | $16.67 M(-18.2%) | $68.10 M(-3.4%) |
| Dec 2003 | $66.02 M(-27.8%) | $20.37 M(+35.6%) | $70.53 M(+53.4%) |
| Sept 2003 | - | $15.03 M(-6.3%) | $45.97 M(-21.6%) |
| June 2003 | - | $16.04 M(-16.0%) | $58.65 M(-25.3%) |
| Mar 2003 | - | $19.09 M(-556.2%) | $78.48 M(-14.2%) |
| Dec 2002 | $91.44 M(+11.9%) | -$4.18 M(-115.1%) | $91.44 M(+0.7%) |
| Sept 2002 | - | $27.70 M(-22.8%) | $90.80 M(-2.3%) |
| June 2002 | - | $35.87 M(+11.9%) | $92.91 M(+19.8%) |
| Mar 2002 | - | $32.05 M(-764.2%) | $77.56 M(+21.7%) |
| Dec 2001 | $81.70 M(-23.2%) | -$4.83 M(-116.2%) | $63.73 M(-43.7%) |
| Sept 2001 | - | $29.82 M(+45.3%) | $113.21 M(+15.0%) |
| June 2001 | - | $20.52 M(+12.6%) | $98.42 M(-15.1%) |
| Mar 2001 | - | $18.22 M(-59.2%) | $115.95 M(+8.4%) |
| Dec 2000 | $106.35 M(+96.9%) | $44.65 M(+197.0%) | $106.96 M(+18.6%) |
| Sept 2000 | - | $15.03 M(-60.5%) | $90.21 M(+8.2%) |
| June 2000 | - | $38.04 M(+312.0%) | $83.38 M(+43.6%) |
| Mar 2000 | - | $9.23 M(-66.9%) | $58.06 M(+7.5%) |
| Dec 1999 | $54.00 M(+60.7%) | $27.90 M(+240.2%) | $54.03 M(+125.8%) |
| Sept 1999 | - | $8.20 M(-35.6%) | $23.93 M(-32.1%) |
| June 1999 | - | $12.73 M(+144.9%) | $35.23 M(+14.4%) |
| Mar 1999 | - | $5.20 M(-336.4%) | $30.80 M(+3.7%) |
| Dec 1998 | $33.60 M(-29.1%) | -$2.20 M(-111.3%) | $29.70 M(-32.7%) |
| Sept 1998 | - | $19.50 M(+134.9%) | $44.10 M(+12.8%) |
| June 1998 | - | $8.30 M(+102.4%) | $39.10 M(-10.7%) |
| Mar 1998 | - | $4.10 M(-66.4%) | $43.80 M(-7.6%) |
| Dec 1997 | $47.40 M(+117.4%) | $12.20 M(-15.9%) | $47.40 M(+3.0%) |
| Sept 1997 | - | $14.50 M(+11.5%) | $46.00 M(+30.7%) |
| June 1997 | - | $13.00 M(+68.8%) | $35.20 M(+34.4%) |
| Mar 1997 | - | $7.70 M(-28.7%) | $26.20 M(+20.2%) |
| Dec 1996 | $21.80 M(-15.5%) | $10.80 M(+191.9%) | $21.80 M(+7.9%) |
| Sept 1996 | - | $3.70 M(-7.5%) | $20.20 M(+2.0%) |
| June 1996 | - | $4.00 M(+21.2%) | $19.80 M(-13.9%) |
| Mar 1996 | - | $3.30 M(-64.1%) | $23.00 M(-10.9%) |
| Dec 1995 | $25.80 M(+11.7%) | $9.20 M(+178.8%) | $25.80 M(+27.1%) |
| Sept 1995 | - | $3.30 M(-54.2%) | $20.30 M(-16.5%) |
| June 1995 | - | $7.20 M(+18.0%) | $24.30 M(+6.6%) |
| Mar 1995 | - | $6.10 M(+64.9%) | $22.80 M(-1.7%) |
| Dec 1994 | $23.10 M(-27.4%) | $3.70 M(-49.3%) | $23.20 M(-39.9%) |
| Sept 1994 | - | $7.30 M(+28.1%) | $38.60 M(+5.5%) |
| June 1994 | - | $5.70 M(-12.3%) | $36.60 M(+0.5%) |
| Mar 1994 | - | $6.50 M(-66.0%) | $36.40 M(+15.2%) |
| Dec 1993 | $31.80 M(+381.8%) | $19.10 M(+260.4%) | $31.60 M(+122.5%) |
| Sept 1993 | - | $5.30 M(-3.6%) | $14.20 M(+34.0%) |
| June 1993 | - | $5.50 M(+223.5%) | $10.60 M(+158.5%) |
| Mar 1993 | - | $1.70 M(0.0%) | $4.10 M(+5.1%) |
| Dec 1992 | $6.60 M(+32.0%) | $1.70 M(0.0%) | $3.90 M(+11.4%) |
| Sept 1992 | - | $1.70 M(-270.0%) | $3.50 M(+16.7%) |
| June 1992 | - | -$1.00 M(-166.7%) | $3.00 M(-43.4%) |
| Mar 1992 | - | $1.50 M(+15.4%) | $5.30 M(+39.5%) |
| Dec 1991 | $5.00 M | $1.30 M(+8.3%) | $3.80 M(+52.0%) |
| Sept 1991 | - | $1.20 M(-7.7%) | $2.50 M(+92.3%) |
| June 1991 | - | $1.30 M | $1.30 M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual gross profit?
- What is the all time high annual gross profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual gross profit year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly gross profit?
- What is the all time high quarterly gross profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly gross profit year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM gross profit?
- What is the all time high TTM gross profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM gross profit year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual gross profit?
The current annual gross profit of VRTX is $8.61 B
What is the all time high annual gross profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual gross profit is $8.61 B
What is Vertex Pharmaceuticals Incorporated annual gross profit year-on-year change?
Over the past year, VRTX annual gross profit has changed by +$756.60 M (+9.64%)
What is Vertex Pharmaceuticals Incorporated quarterly gross profit?
The current quarterly gross profit of VRTX is $2.38 B
What is the all time high quarterly gross profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly gross profit is $2.38 B
What is Vertex Pharmaceuticals Incorporated quarterly gross profit year-on-year change?
Over the past year, VRTX quarterly gross profit has changed by +$214.50 M (+9.91%)
What is Vertex Pharmaceuticals Incorporated TTM gross profit?
The current TTM gross profit of VRTX is $9.15 B
What is the all time high TTM gross profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM gross profit is $9.15 B
What is Vertex Pharmaceuticals Incorporated TTM gross profit year-on-year change?
Over the past year, VRTX TTM gross profit has changed by +$674.00 M (+7.95%)